Balyasny Asset Management
TVTX icon

Balyasny Asset Management’s Travere Therapeutics TVTX Stock Holding History

Balyasny Asset Management’s Portfolio TVTX Stock Details TVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-21,988
Closed -$526K – 3568
2025
Q3 		$526K Buy
+21,988
New +$413K ﹤0.01% 2384
2025
Q2 		– Sell
-190,272
Closed -$3.41M – 3365
2025
Q1 		$3.41M Buy
+190,272
New +$3.86M 0.01% 1436
2024
Q4 		– Sell
-1,285,379
Closed -$18M – 3273
2024
Q3 		$18M Buy
+1,285,379
New +$13.4M 0.03% 682
2023
Q3 		– Sell
-326,570
Closed -$5.02M – 2746
2023
Q2 		$5.02M Buy
+326,570
New +$5.94M 0.01% 1057
2023
Q1 		– Sell
-67,349
Closed -$1.42M – 3175
2022
Q4 		$1.42M Sell
67,349
-344,269
-84% -$7.3M ﹤0.01% 1548
2022
Q3 		$10.1M Buy
411,618
+110,412
+37% +$2.85M 0.03% 679
2022
Q2 		$7.3M Buy
+301,206
New +$7.58M 0.02% 780
2019
Q2 		– Sell
-20,534
Closed -$465K – 1739
2019
Q1 		$465K Buy
20,534
+10,613
+107% +$235K ﹤0.01% 1222
2018
Q4 		$225K Buy
+9,921
New +$247K ﹤0.01% 1282
2017
Q2 		– Sell
-109,072
Closed -$2.01M – 1755
2017
Q1 		$2.01M Buy
+109,072
New +$2.13M 0.01% 907
2016
Q4 		– Sell
-45,000
Closed -$1.01M – 1485
2016
Q3 		$1.01M Buy
+45,000
New +$857K 0.01% 685
2015
Q4 		– Sell
-18,950
Closed -$384K – 1455
2015
Q3 		$384K Buy
+18,950
New +$561K ﹤0.01% 859

Other funds holding TVTX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Balyasny Asset Management's TVTX Position: Q4 2025 in Review

Balyasny Asset Management sold out of Travere Therapeutics (TVTX) in Q4 2025, closing a stake of 21,988 shares — an estimated $526K sold.

Balyasny Asset Management first reported a position in TVTX in Q3 2015 and held it in 12 quarters. The position peaked at $18M in Q3 2024. 278 funds tracked by Wall St. Rank hold TVTX as of Q4 2025.

  • Balyasny Asset Management reported no remaining Travere Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Balyasny Asset Management sold 21,988 Travere Therapeutics shares in Q4 2025, an estimated $526K.
  • Balyasny Asset Management first reported a position in Travere Therapeutics in Q3 2015 and held it in 12 quarters.
  • Balyasny Asset Management's Travere Therapeutics position peaked at $18M in Q3 2024.
  • 278 funds tracked by Wall St. Rank held Travere Therapeutics as of Q4 2025.

Based on Balyasny Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.